Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Jul 24, 2020 11:52am

64 Views

Post# 31314517

TD show again today

V:VXL Depth by Order @11:51:39

Bid			Ask
Broker	Size	Price	Price	Size	Broker
7 TD Sec	20,000	0.11	0.12	30,000	7 TD Sec
7 TD Sec	10,000	0.11	0.12	500	1 Anonymous
7 TD Sec	10,000	0.11	0.125	40,500	9 BMO Nesbitt
7 TD Sec	75,500	0.11	0.125	70,000	9 BMO Nesbitt
68 Leede	68,500	0.105	0.13	5,000	9 BMO Nesbitt
19 Desjardins	10,000	0.10	0.13	500	2 RBC
2 RBC	5,000	0.10	0.13	25,000	85 Scotia
7 TD Sec	20,000	0.10	0.13	10,000	7 TD Sec
2 RBC	36,500	0.095	0.135	10,000	7 TD Sec
7 TD Sec	80,000	0.095	0.135	2,000	80 National Bank